Researcher.Life Logo

Multiple Sclerosis Journal - Experimental, Translational and Clinical : Impact Factor & More

eISSN: 2055-2173pISSN: 2055-2173
JournalOpen Access

Key Metrics

CiteScore
3.3
SJR
Q4Neurology (clinical)
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Multiple Sclerosis Journal - Experimental, Translational and Clinical

Multiple Sclerosis Journal - Experimental, Translational and Clinical Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2000
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Multiple Sclerosis Journal - Experimental, Translational and Clinical

Tumefactive demyelination in older adults: A scoping review of published cases
  • 3 Apr 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Measurement of functional mobility in multiple sclerosis: A crosswalk between the patient-determined disease steps and the Neuro-QoL Lower Extremity Function—Short Form
  • 2 Apr 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists.
  • 1 Apr 2026
  • Multiple sclerosis journal - experimental, translational and clinical
Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study
  • 30 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis
  • 26 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
The interconnection of multiple sclerosis and neurofibromatosis type 1: A single institution retrospective study and systematic review
  • 26 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Tumefactive demyelination in older adults: A scoping review of published cases
  • 3 Apr 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Measurement of functional mobility in multiple sclerosis: A crosswalk between the patient-determined disease steps and the Neuro-QoL Lower Extremity Function—Short Form
  • 2 Apr 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists.
  • 1 Apr 2026
  • Multiple sclerosis journal - experimental, translational and clinical
Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study
  • 30 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis
  • 26 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical
The interconnection of multiple sclerosis and neurofibromatosis type 1: A single institution retrospective study and systematic review
  • 26 Mar 2026
  • Multiple Sclerosis Journal - Experimental, Translational and Clinical

FAQs on Multiple Sclerosis Journal - Experimental, Translational and Clinical